We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Contraceptive Implant Hails New Era of Birth Control

By HospiMedica International staff writers
Posted on 22 Jul 2014
Print article
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).
A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years.

Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup, the device, which measures just 20 x 20 x 7 millimeters, is designed to be implanted under the skin of the buttocks, upper arm, or abdomen. It then dispenses a daily dose levonorgestrel from a reservoir sealed with a titanium and platinum hermetic stopper. Passing an electric current through the stopper melts it temporarily, allowing a 30-microgram dose of the hormone to diffuse out each day.

Women who receive the implant also get a remote control that allows them to halt or restart the implant on demand; to conceive, women turn off the implant with a remote control; another click of the remote restarts it. Doctors could also adjust dosages remotely. MicroCHIPS have previously demonstrated how the microchip technology could release daily doses of an osteoporosis drug. The new application could revolutionize the level of control women have over their birth control technologies.

The technology also includes a secure encryption protocol to prevent outsiders from blocking or reprogramming the implants wirelessly. Another safety factor is that the device is triggered remotely by radio communication over a special frequency called Medical Implant Communication Service (MICS), which only works over a very short distance, almost requiring skin contact to function. The device will begin preclinical testing in the US in 2015, with the goal of market approval by 2018. The study describing the technology was published on July 4, 2014, in MIT Technology Review.

“The idea of using a thin membrane like an electric fuse was the most challenging and the most creative problem we had to solve,” said Robert Farra, president of MicroCHIPS. “We have heard a lot of positive feedback. Women are excited about the capability to change the state of an implant without having to go through another procedure to have it removed. They like the long-term medication, and not having to remember to take medication each day.”

Related Links:
MicroCHIPS
MIT


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Compact C-Arm
Arcovis DRF-C S21

Print article

Channels

Surgical Techniques

view channel
Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.